Table 3 Clinico-pathologic characteristics of 101 EOC patients and their association with LipB mRNA expression

Histological type

Serous vs endometrioid

0.84

0.25-2.22

0.773

Serous vs clear cell

3.43

0.002-0.79

0.027

Serous vs mucinous

1756

0.66-3.83

0.345

Serous vs mixed

1.05

0.51-2.34

0.533

Serous vs undifferentiated

12.99

1.80-7.88

0.007

Endometrioid vs clear cell

4.04

0.66-2.83

0.265

Endometrioid vs mucinous

2069

0.46-3.73

0.487

Endometrioid vs mixed

1.24

0.27-2.32

0.765

Endometrioid vs undifferentiated

15.31

0.96-1.73

0.094

Clear cell vs mucinous

511

0.36-3.52

0.446

Clear cell vs undifferentiated

3.78

0.46-2.94

0.269

Mixed vs clear cell

3.25

0.71-3.72

0.151

Mixed vs mucinous

1660

0.36-3.54

0.412

Mixed vs undifferentiated

12.28

0.007-0.89

0.036

Undifferentiated vs mucinous

135

0.22-3.77

0.990

Histological grade

G2 + G3 vs G1

0.04

0.003-0.59

0.02

FIGO stage

III + IV vs I + II

0.80

0.29-2.14

0.66

Age at diagnosis (y)

>60 vs ≤60

1.09

0.512-2.335

0.58

Residual tumor (RT), cm

RT > 0 vs RT = 0

0.99

0.41-2.38

0.99

Presence of ascites

yes vs no

1.69

0.76-3.73

0.19

Lymph node involvement

positive vs negative

1.03

0.42-2.52

0.94